FDA Adverse Event Injury Summary report: N

FLEXTEND II

MDR report key: 1893703 · Received November 9, 2010

Report

Report Number
2124215-2010-21757
Event Type
Injury
Date Received
November 9, 2010
Date of Event
March 17, 2010
Report Date
August 3, 2010
Manufacturer
CPI - DEL CARIBE
Product Code
NVN
Product Problem
Yes
Report Source
Manufacturer report
Reporter Occupation
PHYSICIAN

Narratives

Additional Manufacturer Narrative · 1

UPON RECEIPT TO THE POST MARKET QUALITY ASSURANCE LABORATORY, A VISUAL INSPECTION REVEALED THE HELIX WAS EXTENDED. A CUT WAS NOTED IN THE SILICONE INSULATION. ANALYSIS REVEALED THE LEAD WAS ELECTRICALLY CONTINUOUS. THE HELIX FAILED TO RETRACT, LIKLEY DUE TO BLOOD IN THE HELIX MECHANISM. ELECTRICALLY, LEAD WAS FOUND TO BE WITHIN SPECIFICATION.

Description of Event or Problem · 1

BOSTON SCIENTIFIC CRM RECEIVED INFORMATION THAT ONE DAY POST IMPLANT THIS ATRIAL LEAD WAS DISLODGED. A REVISION PROCEDURE WAS PERFORMED; THE LEAD WOULD NOT REMAIN IN POSITION. THIS LEAD WAS REMOVED AND REPLACED WITH A NON-BOSTON SCIENTIFIC CRM LEAD. NO ADVERSE PATIENT EFFECTS WERE REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
1 FLEXTEND II IMPLANTABLE LEAD NVN CPI - DEL CARIBE 4096

Patients

Seq Age Sex Outcome Treatment
1 Required Intervention